Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus rhamnosus GG and Improved Gut Microbiota Diversity

Doses used in studies

CFU/day: 60 billion (median 60 billion, IQR 60 billion–60 billion) — 1 study

Time to effect

Median: 4 weeks · IQR 4 weeks–4 weeks · Range 4 weeks–4 weeks — Reported in 1 of 1 study

1 of 1 paper

No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients.
- 2022-06-29
- RCT · n = 81
- Microbiology spectrum 10(3)
- - Ingrid Maria Cecilia Rubin
  - Sarah Mollerup
  - Christa Broholm
  - Signe Boye Knudsen
  - Adam Baker
  - Morten Helms
  - Mona Katrine Alberthe Holm
  - Thomas Kallemose
  - Henrik Westh
  - Jenny Dahl Knudsen
  - Mette Pinholt
  - Andreas Munk Petersen
- PubMed: 35475684
- DOI: 10.1128/spectrum.02348-21
2 Insights on
- Improved Gut Microbiota Diversity
- High evidence
- Clinical
The microbiome analyses revealed no significant difference in alpha diversity between the LGG and the placebo group.
Effect
Neutral
Effect size
Small
Significant
No
Dose
60 billion CFU daily